Coya Therapeutics to Participate in B. Riley Securities’ 2022 Virtual Neuro & Ophthalmology Conference
● Fireside Chat with B. Riley Research Scheduled for Thursday, April 28th, at 10:00 AM…
News
CORRECTING and REPLACING After 15 Years, Del Webb Announces New Active Adult Community in Chicago
Lincoln Prairie by Del Webb will offer single-family ranch homes and resort-style amenities for 55+…
Family Life Academy Charter Schools Add PowerSchool Solutions to Amplify Blended and Social-Emotional Learning Capabilities
New York City charter schools adopt PowerSchool Unified Classroom® Schoology Learning and PowerSchool Unified Classroom®…
Snowden Lane Partners Adds New Investment Solutions Professional
Former Fieldpoint Private VP Joins the Firm as Vice President and Senior Portfolio Consultant NEW…
MCT Continues to Elevate and Deliver Unmatched Client Experience Within Mortgage Capital Markets
Trusted Capital Markets Partner Bolsters Client-Facing Teams with New Hires and Promotions SAN DIEGO–(BUSINESS WIRE)–Mortgage…
Northern Trust Appoints Senior Managing Director to New York Wealth Management Team
Anne Fitzpatrick Donahue assumes role in Greater New York NEW YORK–(BUSINESS WIRE)–Northern Trust has appointed…
IO Biotech Hosting Key Opinion Leader Webinar Series
Part 1: A New Way to Kill Tumors–IO102-IO103 Phase 3 Trial in Combination with Anti-PD-1…
Assertio Holdings, Inc. to Report First Quarter 2022 Financial Results After the Close of Markets on Monday, May 9, 2022
LAKE FOREST, Ill., April 22, 2022 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
Medexus Pharmaceuticals Announces Resubmission of Treosulfan NDA
Additional data collection and analysis reconfirms confidence in New Drug Application for Treosulfan NDA resubmission…
Salarius Pharmaceuticals, Inc. Announces $2.3 Million Registered Direct Offering
HOUSTON, April 22, 2022 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical…
Opthea strengthens its Board of Directors
Elects Mr. Quinton Oswald and Dr. Susan Orr, deeply experienced Ophthalmology Executives, at a General Meeting of Shareholders MELBOURNE, Australia,…
SCYNEXIS Announces Pricing of $45 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants
JERSEY CITY, N.J., April 22, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (Nasdaq: SCYX) today announced…
BioLexis Reorganization Results in GMS Holdings as Largest Shareholder in Outlook Therapeutics
SINGAPORE and ISELIN, N.J., April 22, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK),…
SCYNEXIS Announces Positive Interim Data from Phase 3 FURI and CARES Studies Highlighting Oral Ibrexafungerp’s Potency Against Severe Fungal Infections
Data reinforce findings from previous analyses demonstrating oral ibrexafungerp’s potential to combat difficult-to-treat and refractory…
Vallon Pharmaceuticals Announces Review of Strategic Alternatives
Philadelphia, PA, April 22, 2022 (GLOBE NEWSWIRE) — Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or…
Jasper Therapeutics to Host In-Person Key Opinion Leader Webinar on Transforming Hematopoietic Stem Cell Therapies
REDWOOD CITY, Calif., April 22, 2022 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a…
Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2022 Financial Results
SAN DIEGO, April 22, 2022 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate…
Emerging Markets Report: More Tools in the Toolbox
An Emerging Markets Sponsored Commentary ORLANDO, Fla., April 22, 2022 (GLOBE NEWSWIRE) — Sometimes as…
PLx Pharma Inc. to Discuss 2022 First Quarter Financial Results on May 13, 2022 Conference Call and Provide Business Update
SPARTA, N.J., April 22, 2022 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the…
Cellebrite Named a Leader in Inaugural IDC MarketScape on Digital Forensics
Cellebrite is recognized for cutting-edge solutions paired with end-to-end investigative workflow innovation PETAH TIKVA, Israel…